These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 4398939)

  • 41. Functional mechanism of the striatum by integration of nine types of synapses which have at least seven different transmitters.
    Hassler R
    Int J Neurol; 1979; 13(1-4):94-116. PubMed ID: 45452
    [No Abstract]   [Full Text] [Related]  

  • 42. Cholinergic mechanism--monoamines relation in certain brain structures.
    Izquierdo JA
    Prog Drug Res; 1972; 16():334-63. PubMed ID: 4405290
    [No Abstract]   [Full Text] [Related]  

  • 43. Catecholamines in fetal and newborn rat brain.
    Coyle JT; Henry D
    J Neurochem; 1973 Jul; 21(1):61-7. PubMed ID: 4146461
    [No Abstract]   [Full Text] [Related]  

  • 44. A role of the polysynaptic system of substantia nigra in the cholinergic-dopaminergic equilibrium in the central nervous system.
    Wolfarth S; Dulska E; GoĊ‚embiowska-Nikitin K; Vetulani J
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Apr; 302(2):123-31. PubMed ID: 652058
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacology of the central nervous system.
    Nelson SR; Walaszek EJ
    Prog Neurol Psychiatry; 1971; 26():123-49. PubMed ID: 4151158
    [No Abstract]   [Full Text] [Related]  

  • 46. Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA).
    Hornykiewicz O
    Br Med Bull; 1973 May; 29(2):172-8. PubMed ID: 4356552
    [No Abstract]   [Full Text] [Related]  

  • 47. Dopamine and extrapyramidal motor function and dysfunction.
    Hornykiewicz O
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():390-415. PubMed ID: 4561070
    [No Abstract]   [Full Text] [Related]  

  • 48. Dopamine, extrapyramidal system, and psychomotor function.
    Papeschi R
    Psychiatr Neurol Neurochir; 1972; 75(1):13-48. PubMed ID: 4625495
    [No Abstract]   [Full Text] [Related]  

  • 49. Evidence for a dopamine inhibitory post-synaptic potential in the brain of Helix aspersa.
    Walker RJ; Ralph KL; Woodruff GN; Kerkut GA
    Comp Gen Pharmacol; 1971 Mar; 2(5):15-26. PubMed ID: 5162652
    [No Abstract]   [Full Text] [Related]  

  • 50. [Correlations between chemical mediators (dopamine, serotonin, acetylcholine and gaba), muscular tone and rapidity of movement].
    Hassler R
    Rev Neurol (Paris); 1972 Jul; 127(1):51-63. PubMed ID: 4358575
    [No Abstract]   [Full Text] [Related]  

  • 51. [Functional morphology of mediator systems of the brain].
    Otellin VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(1):54-8. PubMed ID: 9505409
    [No Abstract]   [Full Text] [Related]  

  • 52. The efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role?
    Agid Y; Graybiel AM; Ruberg M; Hirsch E; Blin J; Dubois B; Javoy-Agid F
    Adv Neurol; 1990; 53():83-100. PubMed ID: 1978522
    [No Abstract]   [Full Text] [Related]  

  • 53. Dopamine-stimulated adenylate cyclase in rat substantia nigra: localization and effects of neuroleptics.
    Spano PF; Di Chiara G; Loddo P; Tonon GC; Trabucchi M
    Adv Biochem Psychopharmacol; 1977; 16():613-6. PubMed ID: 18903
    [No Abstract]   [Full Text] [Related]  

  • 54. Apomorphine and its effects on the spinal cord.
    Schlosser W; Horst WD; Spiegel HE; Sigg EB
    Neuropharmacology; 1972 May; 11(3):417-26. PubMed ID: 4340498
    [No Abstract]   [Full Text] [Related]  

  • 55. Auto- and postsynaptic dopamine receptors in the central nervous system.
    Rebec GV
    Monogr Neural Sci; 1984; 10():207-23. PubMed ID: 6321971
    [No Abstract]   [Full Text] [Related]  

  • 56. Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agent.
    Johnson AM; Vigouret JM; Loew DM
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R40. PubMed ID: 4276573
    [No Abstract]   [Full Text] [Related]  

  • 57. Catalepsy, sedation and hypothermia induced by alpha-methyl-p-tyrosine in the rat. An ideal tool for screening of drugs active on central catecholaminergic receptors.
    Papeschi R; Randrup A
    Pharmakopsychiatr Neuropsychopharmakol; 1973 May; 6(3):137-57. PubMed ID: 4800160
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of central acting drugs on serum and pituitary prolactin levels in rats.
    Lu KH; Amenomori Y; Chen CL; Meites J
    Endocrinology; 1970 Oct; 87(4):667-72. PubMed ID: 5453281
    [No Abstract]   [Full Text] [Related]  

  • 59. An analysis of DOPA-induced locomotor stimulation in mice with inhibited extracerebral decarboxylase.
    PrzegaliĊ„ski E; Kleinrok Z
    Psychopharmacologia; 1972; 23(3):279-88. PubMed ID: 4260342
    [No Abstract]   [Full Text] [Related]  

  • 60. The occurrence of biogenic monoamines in the mammalian endocrine pancreas.
    Cegrell L
    Acta Physiol Scand Suppl; 1968; 314():1-60. PubMed ID: 4973243
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.